Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 26, 2005. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial statements or performance metrics.
Material Changes
The only material change reported is a transaction involving the GlaxoSmithKline Employee Trust ("the GSK Trust"). On May 24, 2005, the trust transferred 5,024 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The company was advised of these transactions on May 25, 2005.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. It strictly details the mechanics of the share transfer and notes that three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) are interested in the shares held in the GSK Trust in the same capacity as other employees.
Key Facts for Investor Verification
- 5,024 Ordinary Shares were transferred from the GSK Trust to employee plan participants on May 24, 2005.
- Three directors hold interests in the GSK Trust as potential beneficiaries alongside other employees.
- This filing does not contain financial performance data for the period.